Follow
Renate de Boer
Renate de Boer
Unknown affiliation
Verified email at amsterdamumc.nl
Title
Cited by
Cited by
Year
Allo-HLA reactivity of virus-specific memory T cells is common
AL Amir, LJA D'Orsogna, DL Roelen, MM van Loenen, RS Hagedoorn, ...
Blood, The Journal of the American Society of Hematology 115 (15), 3146-3157, 2010
3342010
Mixed T cell receptor dimers harbor potentially harmful neoreactivity
MM van Loenen, R de Boer, AL Amir, RS Hagedoorn, GL Volbeda, ...
Proceedings of the National Academy of Sciences 107 (24), 10972-10977, 2010
2792010
PRAME-specific allo-HLA–restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer
AL Amir, DM van der Steen, MM van Loenen, RS Hagedoorn, R de Boer, ...
Clinical Cancer Research 17 (17), 5615-5625, 2011
1522011
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
JH van den Berg, B Heemskerk, N van Rooij, R Gomez-Eerland, ...
Journal for immunotherapy of cancer 8 (2), 2020
1142020
Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment
I de Weerdt, T Hofland, R de Boer, JA Dobber, J Dubois, ...
Blood advances 3 (17), 2642-2652, 2019
1012019
Eerste evaluatie Jeugdwet: Na de transitie nu de transformatie
RD Friele, MR Bruning, ILW Bastiaanssen, R De Boer, A Bucx, ...
ZonMw, 2018
632018
The molecular bases of δ/αβ T cell–mediated antigen recognition
DG Pellicci, AP Uldrich, J Le Nours, F Ross, E Chabrol, SBG Eckle, ...
Journal of Experimental Medicine 211 (13), 2599-2615, 2014
622014
Pulmonary immune responses against Aspergillus fumigatus are characterized by high frequencies of IL-17 producing T-cells
H Jolink, R de Boer, P Hombrink, RE Jonkers, JT van Dissel, ...
Journal of Infection 74 (1), 81-88, 2017
552017
A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells
MM van Loenen, R de Boer, E van Liempt, P Meij, I Jedema, ...
Haematologica 99 (4), 759, 2014
502014
Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies
MM van Loenen, R de Boer, RS Hagedoorn, EHM van Egmond, ...
Haematologica 96 (3), 477, 2011
502011
Mixed functional characteristics correlating with TCR‐ligand koff‐rate of MHC‐tetramer reactive T cells within the naive T‐cell repertoire
P Hombrink, Y Raz, MGD Kester, R de Boer, B Weißbrich, ...
European journal of immunology 43 (11), 3038-3050, 2013
442013
A bispecific single-domain antibody boosts autologous Vγ9Vδ2-T cell responses toward CD1d in chronic lymphocytic leukemia
I de Weerdt, R Lameris, JM Ruben, R de Boer, J Kloosterman, LA King, ...
Clinical Cancer Research 27 (6), 1744-1755, 2021
322021
HA-1H T-cell receptor gene transfer to redirect virus-specific T cells for treatment of hematological malignancies after allogeneic stem cell transplantation: a phase 1 …
P van Balen, I Jedema, MM van Loenen, R de Boer, HM van Egmond, ...
Frontiers in Immunology 11, 1804, 2020
262020
Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantation
PLJ van der Heiden, R de Boer, DM van der Steen, MGD Kester, ...
Journal of virology 83 (14), 7361-7364, 2009
262009
Multi-cistronic vector encoding optimized safety switch for adoptive therapy with T-cell receptor-modified T cells
MM Van Loenen, R De Boer, RS Hagedoorn, V Jankipersadsing, AL Amir, ...
Gene therapy 20 (8), 861-867, 2013
252013
A bispecific antibody antagonizes prosurvival CD40 signaling and promotes Vγ9Vδ2 T cell–mediated antitumor responses in human B-cell malignancies
I de Weerdt, R Lameris, GL Scheffer, J Vree, R de Boer, AG Stam, ...
Cancer immunology research 9 (1), 50-61, 2021
242021
T helper 2 response in allergic bronchopulmonary aspergillosis is not driven by specific Aspergillus antigens
H Jolink, R De Boer, LNA Willems, JT Van Dissel, JHF Falkenburg, ...
Allergy 70 (10), 1336-1339, 2015
222015
Elevated folate levels in amniotic fluid after oral supplementation
RPM Steegers-Theunissen, EAP Steegers, R De Boer, CMG Thomas, ...
European Journal of Obstetrics & Gynecology and Reproductive Biology 36 (3 …, 1990
221990
Natural killer cell hypo-responsiveness in chronic lymphocytic leukemia can be circumvented in vitro by adequate activating signaling
T Hofland, S Endstra, CKP Gomes, R De Boer, I De Weerdt, V Bobkov, ...
Hemasphere 3 (6), e308, 2019
212019
Dissection of the effects of JAK and BTK inhibitors on the functionality of healthy and malignant lymphocytes
T Hofland, I de Weerdt, H Ter Burg, R de Boer, S Tannheimer, SH Tonino, ...
The Journal of Immunology 203 (8), 2100-2109, 2019
192019
The system can't perform the operation now. Try again later.
Articles 1–20